HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer.

AbstractINTRODUCTION:
Recent large epidemiologic population-based studies identified gamma-glutamyltransferase (GGT) as a marker for increased cervical cancer incidence. Furthermore, high levels of GGT seem to increase the risk of progression of high-grade cervical dysplasia to invasive carcinoma. Therefore, we evaluated the association between pre-therapeutic serum GGT levels, tumor stage and prognosis in patients with cervical cancer.
MATERIALS AND METHODS:
In this multi-center trial, pre-therapeutic GGT levels were examined in 692 patients with cervical cancer. GGT levels were correlated with clinico-pathological parameters. Patients were assigned to previously described GGT risk groups and uni- and multivariable survival analyses were performed.
RESULTS:
GGT serum levels were associated with FIGO stage (p<0.0001) and age (r=0.2, p<0.0001) but not with lymph node involvement (p=0.85), and histological type (p=0.98). High-risk GGT group affiliation (p=0.01 and p<0.0001) was associated with poor disease-free and overall survival in a univariate analysis, but not in a multivariable Cox-regression model (p=0.59 and p=0.171). We further investigated the association between prognosis and GGT and observed a linear correlation between GGT and prognosis. Therefore we were not able to identify a clear prognostic cut-off value for GGT in patients with cervical cancer.
CONCLUSIONS:
High GGT--a marker for apoptosis and cervical cancer risk--is associated with advanced tumor stage in patients with cervical cancer.
AuthorsStephan Polterauer, Gerda Hofstetter, Christoph Grimm, Jasmin Rahhal, Mariella Mailath-Pokorny, Maria Kohl, Nicole Concin, Clemens Tempfer, Christian Marth, Alexander Reinthaller
JournalGynecologic oncology (Gynecol Oncol) Vol. 122 Issue 3 Pg. 590-4 (Sep 2011) ISSN: 1095-6859 [Electronic] United States
PMID21664662 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • gamma-Glutamyltransferase
Topics
  • Apoptosis (physiology)
  • Biomarkers, Tumor (blood)
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis
  • Uterine Cervical Neoplasms (enzymology, pathology)
  • gamma-Glutamyltransferase (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: